Development and application of an in vitro model for screening anti‐hepatitis B virus therapeutics
Pietro Lampertico, James S. Malter, Michael A. Gerber – 1 March 1991 – The development of effective anti‐hepatitis B virus agents has been hampered by the lack of reliable in vitro systems for the screening of new therapeutics. In an effort to circumvent this problem, we have developed an in vitro system for screening antihepatitis B virus drugs using hepatitis B virus DNAtransfected Hep G2 cells. The cell line designated 2.2.15 produces replicative viral DNA intermediates, mature Dane particles and high levels of viral antigens.